Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc.

CPIX

Get informed when a big investor buys or sells

+ Follow
Market Cap$109.68M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Cumberland Pharmaceuticals Inc.Cumberland Pharmaceuticals Inc.-10.220.49%-61%40.3
$10.91

Current Fair Value

37.3% upside

Undervalued by 37.3% based on the discounted cash flow analysis.

Share Statistics

Market cap$109.68 Million
Enterprise Value$110.53 Million
Dividend Yield$1.50 (20.49%)
Earnings per Share$-0.19
Beta0.1
Outstanding Shares14,981,607

Return

Return on Equity-60.82%ROE
Return on Assets-16.87%
Return on Invested Capital-35.68%

Valuation & Multiples

P/E Ratio-10.25P/E Ratio
PEG-2.25PEG
Price to Sales3.97Price to Sales
Price to Book Ratio7.94Price to Book Ratio
Enterprise Value to Revenue3.53
Enterprise Value to EBIT-11.19
Enterprise Value to Net Income-11
Total Debt to Enterprise0.04
Debt to Equity0.27Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 11, 2026
EPS Estimate
$-0.13
Average shareholder expectation
Revenue Estimate
$8.57 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 3, 2026
EPS Estimate
$-0.13
Average shareholder expectation
Revenue Estimate
$8.50 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.5290▲ 14.21%
Total Calls234,400▲ 115.44%
Total Puts124,000▲ 194.54%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %16.48%▼ 1.98%
Total Invested$16.00M▲ 78.29%
Investors Holding37▲ 3.00%

ESG Score

No data

About Cumberland Pharmaceuticals Inc.

90 employees

Cumberland Emerging Technologies, Inc.(www.cet-fund.com)is a joint initiative between Cumberland Pharmaceuticals Inc., Vanderbilt University, LaunchTN and WinHealth Pharma. The mission of CET is to bring biomedical technologies and produ...